RecruitingNot ApplicableNCT07109947

Use of Aromatase Inhibitor Before Misoprostol in Medical Termination of Miscarriage

Comparison Between the Use of Aromatase Inhibitor Before Misoprostol and Use of Misoprostol Alone in Medical Termination of Miscarriage


Sponsor

Aswan University

Enrollment

70 participants

Start Date

Jul 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Abortion is one of the most common complications of pregnancy. Missed abortion is a type of abortions, occurs in 15%-20% of clinically diagnosed pregnancies and is defined as the retention of pregnancy products in the uterus for several days or weeks after death of the fetus.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Letrozole 2.5mg for people with miscarriage. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLetrozole 2.5mg

to determine the effect of Letrozole as a premedication before misoprostol treatment used to induce missed miscarriage.


Locations(1)

Aswan University Hospital

Aswān, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07109947


Related Trials